BioSpace News Archive

Deals

Axovant Gene Therapies Announces Name Change to Sio Gene Therapies

Axovant Gene Therapies Ltd., a clinical-stage gene therapy company developing innovative gene therapies for neurodegenerative diseases, announced it will change its name to Sio Gene Therapies, Inc., effective November 13, 2020.

November 10, 2020
·
5 min read
Biotech Beach

aTyr Pharma Announces Discovery of New Receptor Targets for Two tRNA Synthetases from its Pipeline

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has identified receptor targets for two tRNA synthetases from its pipeline.

November 10, 2020
·
4 min read
XPhyto Secures Exclusive Psychedelic Drug Development Agreement

Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics

November 10, 2020
·
4 min read
BioMidwest

Immunophotonics Announces First Patient Treated in Clinical Study Evaluating IP-001 in Patients with Advanced Solid Tumors

Immunophotonics, Inc. announces the first patient treated in the phase 1b/2a clinical trial examining IP-001 in thermally ablated solid tumors.

November 10, 2020
·
2 min read
Business

IRRAS AB publishes Interim Report for the period January to September 2020

During the third quarter IRRAS made decisive progress in a number of areas.

November 10, 2020
·
3 min read
Business

Medivir AB - Interim Report January - September 2020

In July, a research collaboration was initiated with the Drug Discovery and Development Platform (DDD) at SciLifeLab on potential inhibitors of SARS CoV-2.

November 10, 2020
·
5 min read
BioCapital

Fina Biosolutions Announces European Patent for Conjugate Vaccine Development

Fina Biosolutions LLC (“FinaBio”) is pleased to announce that it has received a Certificate of Patent entitled “Expression and Purification of CRM Proteins and Related Proteins, and Protein Domains” from the European Patent Office (EPO).

November 10, 2020
·
3 min read
BioMidwest

JOMS study: Hoverboard head injuries more severe in adults

A new study finds head injuries involving hoverboards are more severe among adults; therefore, the researchers recommend helmet use to help prevent injuries.

November 10, 2020
·
4 min read
HitGen Licenses Its Trk/ROS1 Inhibitor HG030 to Baiyunshan for Development and Commercialisation in China

HitGen Inc. announces it has entered into a collaboration and licensing agreement with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd to develop and commercialise its HG030 programme in mainland China.

November 10, 2020
·
6 min read
Business

Freudenberg Medical Opens New Global Headquarters and Facility Expansion in Massachusetts

Freudenberg Medical, member of the Freudenberg Group and a global developer and manufacturer of specialty components and finished devices for the medical device industry, has completed construction of a new medical manufacturing operation in Beverly, Massachusetts.

November 10, 2020
·
3 min read